Unknown

Dataset Information

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer.


ABSTRACT: Background: Gastric cancer (GC) is a multifactorial progressive disease with high mortality and heterogeneous prognosis. Effective prognostic biomarkers for GC were critically needed. Hippo signaling pathway is one of the critical mechanisms regulating the occurrence and development of GC, and has potential clinical application value for the prognosis and treatment of GC patients. However, there is no effective signature based on Hippo signaling pathway-related genes (HSPRGs) to predict the prognosis and treatment response of GC patients. Our study aimed to build a HSPRGs signature and explore its performance in improving prognostic assessment and drug therapeutic response in GC. Methods: Based on gene expression profiles obtained from The Cancer Genome Atlas (TCGA) database,

SUBMITTER: Jiang R 

PROVIDER: S-EPMC9873967 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature